Shuji Ozaki
Tokushima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
PTHrP-producing diffuse large B-cell lymphoma presenting with hypercalcemia at diagnosis
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: May 13, 2026
Marked Platelet Clumping and Giant Platelets due to GP Ib/IX Autoantibodies.
Journal: American journal of hematology
Published: September 12, 2025
Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma.
Journal: Blood cancer journal
Published: August 07, 2025
Hemostatic therapy for hemorrhagic cholecystitis in a patient with hemophilia A with inhibitors
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: June 04, 2025
HIV-associated neurocognitive dysfunction in the Chugoku-Shikoku region of Japan: A cross-sectional study.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: February 13, 2025
Prognostic value of minimal residual disease detected by EuroFlow next-generation flow cytometry and next-generation sequencing in patients with multiple myeloma achieving complete response and receiving lenalidomide maintenance after autotransplant: a prospective comparison study.
Journal: Haematologica
Published: January 22, 2025
Multiple myeloma with t (8;14) and t (11;14) and extramedullary infiltration of multiple organs
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: July 03, 2024
Elotuzumab-mediated ADCC with Th1-like Vγ9Vδ2 T cells to disrupt myeloma-osteoclast interaction.
Journal: Cancer science
Published: June 04, 2024
Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors.
Journal: International journal of hematology
Published: August 12, 2023
Successful treatment of traumatic intramuscular hemorrhage with coagulation factor VIII replacement in a patient with congenital hemophilia A with decreased inhibitor activity by emicizumab therapy
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: April 05, 2023
Last Updated: 09/26/2026